Current drug treatment of epilepsy in adults

Lancet Neurology

Volumn 3, Issue 12, 2004, Pages 729-735

  McCorry, Dougall ^a   Chadwick, David ^a   Marson, Anthony ^a  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

CHRONIC TOXICITY; CLINICAL TRIAL; DEVELOPMENTAL DISORDER; DROWSINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; EPILEPSY; FOCAL EPILEPSY; FRACTURE; GRAND MAL SEIZURE; HUMAN; MONOTHERAPY; NAUSEA; NEURAL TUBE DEFECT; OSTEOMALACIA; OSTEOPOROSIS; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; STEVENS JOHNSON SYNDROME; TERATOGENICITY; TONIC CLONIC SEIZURE; TREATMENT FAILURE; VISUAL FIELD DEFECT;

ADULT; ANTICONVULSANTS; CLINICAL TRIALS; DRUG THERAPY, COMBINATION; EPILEPSY; HUMANS;

EID: 8844277675     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(04)00935-4     Document Type: Review

References (54)

1. National Institute of Clinical Excellence. Newer drugs for adults with epilepsy, full guidance (TA76). March 2004. www.nice.org.uk/pdf/ TA076fullguidance.pdf (accessed Nov 2, 2004).
2. Annegers JF, Hauser WA, Elveback LR. Remission of seizures and relapse in patients with epilepsy. Epilepsia. 20:1979;729-737
3. Medical Research Council Antiepileptic Drug Withdrawal Study Group. Randomised study of antiepileptic drug withdrawal in patients in remission. Lancet. 337:1991;1175-1180
4. Walker MC, White HS, Sander JW. Disease modification in partial epilepsy. Brain. 125:2002;1937-1950
5. Berg AT, Shinnar S. Do seizures beget seizures? An assessment of the clinical evidence in humans. J Clin Neurophysiol. 14:1997;102-110
6. Temkin NR. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia. 42:2001;515-524
7. Musicco M, Beghi E, Solari A, Viani F. Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group). Neurology. 49:1997;991-998
8. Perucca E, Gram L, Avanzini G, Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia. 39:1998;5-17
9. Snead OC 3rd, Hosey LC. Exacerbation of seizures in children by carbamazepine. N Engl J Med. 313:1985;916-921
10. Shields WD, Saslow E. Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children. Neurology. 33:1983;1487-1489
11. Liporace JD, Sperling MR, Dichter MA. Absence seizures and carbamazepine in adults. Epilepsia. 35:1994;1026-1028
12. Commission on Antiepileptic Drugs. Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy. Epilepsia. 39:1998;799-803
13. Marson AG, Williamson PR, Clough H, Hutton JL, Chadwick DW, Epilepsy Monotherapy Trial Group. Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis. Epilepsia 2002; 43: 505-513.
14. Tudur Smith C, Marson AG, Williamson PR. Carbamazepine versus phenobarbitone monotherapy for epilepsy (Cochrane Review). In: The Cochrane Library, Issue 4, 2004. Chichester, UK: John Wiley & Sons, Ltd.
15. Taylor S, Tudur Smith C, Williamson PR, Marson AG. Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures (Cochrane Review). In: The Cochrane Library, Issue 4, 2004. Chichester, UK: John Wiley & Sons, Ltd.
16. Tudur Smith C, Marson AG, Williamson PR. Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures (Cochrane Review). In: The Cochrane Library, Issue 4, 2004. Chichester, UK: John Wiley & Sons, Ltd.
17. Scottish Intercollegiate Guidelines Network. Diagnosis and management of epilepsy in adults. A national clinical guideline. April 2003. www.sign.ac.uk/pdf/sign70.pdf (accessed Nov 2, 2004).
18. Wallace H, Shorvon SD, Hopkins A, O'Donoghue M. Guidelines for the clinical management of adults with poorly controlled epilepsy. 1997;Royal College of Physicians, London
19. Marson AG, Kadir ZA, Chadwick DW. New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ. 313:1996;1169-1174
20. Marson AG, Hutton JL, Leach JP, et al. Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review. Epilepsy Res. 46:2001;259-270
21. Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/ Carbamazepine Monotherapy Trial Group. Lancet. 345:1995;476-479
22. Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res. 37:1999;81-87
23. Nieto-Barrera M, Brozmanova M, Capovilla G, et al. A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res. 46:2001;145-155
24. Reunanen M, Dam M, Yuen AW. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsy Res. 23:1996;149-155
25. Chadwick DW, Anhut H, Greiner MJ, et al. A double-blind trial of gabapentin monotherapy in patients for newly-diagnosed partial seizures. Neurology. 51:1998;1282-1288
26. Privitera MD, Brodie MJ, Mattson RH, et al. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand. 107:2003;165-175
27. Dam M, Ekberg R, Loyning Y, Waltimo O, Jakobsen K. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res. 3:1989;70-76
28. Reinikainen KJ, Keranen T, Halonen T, Komulainen H, Riekkinen PJ. Comparison of oxcarbazepine and carbamazepine: a double-blind study. Epilepsy Res. 1:1987;284-289
29. Guerreiro MM, Vigonius U, Pohlmann H, et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res. 27:1997;205-213
30. Bill PA, Vigonius U, Pohlmann H, et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Res. 27:1997;195-204
31. Christe W, Kramer G, Vigonius U, et al. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res. 26:1997;451-460
32. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 30:1989;389-399
33. Delgado-Escueta AV, Enrile-Bacsal F. Juvenile myoclonic epilepsy of Janz. Neurology. 34:1984;285-294
34. Nicolson A, Appleton RE, Chadwick DW, Smith DF. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. J Neurol Neurosurg Psychiatry. 75:2004;75-79
35. Iannetti P, Spalice A, Perla FM, Conicella E, Raucci U, Bizzarri B. Visual field constriction in children with epilepsy on vigabatrin treatment. Pediatrics. 106:2000;838-842
36. Luchetti A, Amadi A, Gobbi G. Visual field defects associated with vigabratin monotherapy in children. J Neurol Neurosurg Psychiatry. 69:2000;566
37. Sills GJ, Butler E, Forrest G, Ratnaraj N, Patsalos PN, Brodie MJ. Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the gaba shunt in rat brain and retina. Epilepsia. 44:2003;886-892
38. Elterman RD, Shields WD, Mansfield KA, Nakagawa J, US Infantile Spasms Vigabatrin Study Group. Randomized trial of vigabatrin in patients with infantile spasms [comment]. Neurology 2001; 57: 1416-21.
39. Chiron C, Dumas C, Jambaque I, Mumford J, Dulac O. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res. 26:1997;389-395
40. Dent CE, Richens A, Rowe DJ, Stamp TC. Osteomalacia with long-term anticonvulsant therapy in epilepsy. BMJ. 4:1970;69-72
41. Vestergaard P, Tigaran S, Rejnmark L, Tigaran C, Dam M, Mosekilde L. Fracture risk is increased in epilepsy. Acta Neurol Scand. 99:1999;269-275
42. Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology. 58:2002;1348-1353
43. Pack AM, Olarte LS, Morrell MJ, Flaster E, Resor SR, Shane E. Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav. 4:2003;169-174
44. Sato Y, Kondo I, Ishida S, et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology. 57:2001;445-449
45. Akin R, Okutan V, Sarici U, Altunbas A, Gokcay E. Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr Neurol. 19:1998;129-131
46. Valimaki MJ, Tiihonen M, Laitinen K, et al. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Miner Res. 9:1994;631-637
47. Royal College of Physicians Consensus Group. Osteoporosis - clinical guidelines: summary and recommendations. 1999;1-13 Royal College of Physicians, London
48. Yerby MS. Management issues for women with epilepsy: neural tube defects and folic acid supplementation. Neurology. 61:(suppl 2):2003;S23-26
49. Adab N, Jacoby A, Smith D, Chadwick D. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry. 70:2001;15-21
50. Morrow JI, Russell A, Irwin B, et al. The UK Epilepsy and Pregnancy Register Interim results. In: Proceedings of the Association of British Neurologists Autumn Meeting, 1-3 October 2003. J Neurol Neurosurg Psychiatry. 75:2004;797-806
51. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 342:2000;314-319
52. Kwan P, Brodie MJ. Epilepsy after the first drug fails: substitution or add-on? Seizure. 9:2000;464-468
53. Beghi E, Gatti G, Tonini C, et al. Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial. Epilepsy Res. 57:2003;1-13
54. Deckers CL, Czuczwar SJ, Hekster YA, et al. Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia. 41:2000;1364-1374